Bitopertin (DISC-1459)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bitopertin (DISC-1459), covering 2025-12-18 to 2025-12-18. Get the full timeline:
Most recent: Clinical Trial Update: HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP [Phase 2, Phase 3]